Search Results - "Chun, Yun S"

Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases by Yamashita, Suguru, Venkatesan, Aradhana M, Mizuno, Takashi, Aloia, Thomas A, Chun, Yun S, Lee, Jeffrey E, Vauthey, Jean-Nicolas, Conrad, Claudius

“…Ischemia-reperfusion injury during hepatic resection has been shown to accelerate progression of liver cancer. However, the prognostic relevance of remnant…”
Get more information

Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection by Passot, Guillaume, MD, PhD, Denbo, Jason W., MD, Yamashita, Suguru, MD, PhD, Kopetz, Scott E., MD, Chun, Yun S., MD, FACS, Maru, Dipen, MD, Overman, Michael J., MD, Brudvik, Kristoffer Watten, MD, PhD, Conrad, Claudius, MD, PhD, Aloia, Thomas A., MD, FACS, Vauthey, Jean-Nicolas, MD, FACS

“…Background RAS mutations are associated with limited overall survival after resection of colorectal liver metastases. Our aim was to determine criteria for…”
Get full text

Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: Analysis of 1,557 consecutive liver resections by Palavecino, Martin, MD, Kishi, Yoji, MD, Chun, Yun S., MD, Brown, David L., MD, Gottumukkala, Vijaya N.R., MD, Lichtiger, Benjamin, MD, Curley, Steven A., MD, Abdalla, Eddie K., MD, Vauthey, Jean-Nicolas, MD

“…Background Blood transfusions are an independent risk factor for adverse outcomes after hepatectomy. In-hospital transfusions are still reported in one third…”
Get full text

Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival by Palavecino, Martin, MD, Chun, Yun S., MD, Madoff, David C., MD, Zorzi, Daria, MD, Kishi, Yoji, MD, Kaseb, Ahmed O., MD, Curley, Steven A., MD, Abdalla, Eddie K., MD, Vauthey, Jean-Nicolas, MD

“…Background Preoperative portal vein embolization (PVE) is performed to minimize perioperative risks of major hepatic resection for hepatocellular carcinoma…”
Get full text

Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis by Chun, Yun S., Wang, Linan, Nascimento, Antonio G., Moir, Christopher R., Rodeberg, David A.

“…Background Pediatric inflammatory myofibroblastic tumor (IMT) is rare, with unpredictable clinical behavior. Recently, it has been associated with anaplastic…”
Get full text

Comparative effectiveness of first‐line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma by Kutlu, Onur C., Chan, Jennifer A., Aloia, Thomas A., Chun, Yun S., Kaseb, Ahmed O., Passot, Guillaume, Yamashita, Suguru, Vauthey, Jean‐Nicolas, Conrad, Claudius

“…BACKGROUND Significant controversy exists as to which treatment modality is most effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency…”
Get full text

Overall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization by Denbo, Jason W., Kim, Bradford J., Vauthey, Jean-Nicolas, Tzeng, Ching-Wei, Ma, Jingfei, Huang, Steven Y., Chun, Yun S., Katz, Matthew H. G., Aloia, Thomas A.

“…Purpose To explore whether body composition and/or sarcopenia are associated with liver hypertrophy following portal vein embolization (PVE) in patients with…”
Get full text

Reproducibility and efficiency of liver volumetry using manual method and liver analysis software by Maki, Harufumi, Nishioka, Yujiro, Haddad, Antony, Lendoire, Mateo, Tran Cao, Hop S., Chun, Yun S., Tzeng, Ching-Wei D., Vauthey, Jean-Nicolas, Newhook, Timothy E.

“…For liver volumetry, manual tracing on computed tomography (CT) images is time-consuming and operator dependent. To overcome these disadvantages, several…”
Get full text

RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases by Denbo, Jason W., Yamashita, Suguru, Passot, Guillaume, Egger, Michael, Chun, Yun S., Kopetz, Scott E., Maru, Dipen, Brudvik, Kristoffer Watten, Wei, Steven H., Conrad, Claudius, Vauthey, Jean-Nicolas, Aloia, Thomas A.

“…Background The relationship between RAS mutation status and outcome for patients undergoing repeat hepatectomy (RH) for recurrent colorectal liver metastases…”
Get full text

Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion by Kothari, Anai N., Massarweh, Nader N., Flitcroft, Madelyn A., Newhook, Timothy, Tzeng, Ching-Wei D., Chun, Yun S., Kaseb, Ahmed O., Vauthey, Jean-Nicolas, Tran Cao, Hop S.

“…The role of hepatectomy for hepatocellular carcinoma (HCC) with multifocality or intrahepatic vascular involvement remains ill-defined. Our objective was to…”
Get full text

Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors by Vega, Eduardo A., Vinuela, Eduardo, Okuno, Masayuki, Joechle, Katharina, Sanhueza, Marcel, Diaz, Cristian, Jarufe, Nicolas, Martinez, Jorge, Troncoso, Andres, Diaz, Alfonso, Chun, Yun S., Tzeng, Ching-Wei D., Lee, Jeffrey E., Vauthey, Jean-Nicolas, Conrad, Claudius

“…Conflicting data exists whether non-oncologic index cholecystectomy (IC) leading to discovery of incidental gallbladder cancer (IGBC) negatively impacts…”
Get full text

Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements by Abdalla, Eddie K, Bauer, Todd W, Chun, Yun S, D'Angelica, Michael, Kooby, David A, Jarnagin, William R

“…Abstract Selection of the optimal surgical and interventional therapies for advanced colorectal cancer liver metastases (CRLM) requires multidisciplinary…”
Get full text

Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors by Martin, Allison N., Tzeng, Ching-Wei D., Arvide, Elsa M., Skibber, John M., Chang, George J., Nancy You, Yi-Qian, Bednarski, Brian K., Uppal, Abhineet, Dewhurst, Whitney L., Cristo, Jenilette V., Chun, Yun S., Tran Cao, Hop S., Vauthey, Jean-Nicolas, Newhook, Timothy E.

“…Simultaneous resection of colorectal liver metastases (CLM) and primary colorectal cancers (CRC) is nuanced without firm rules for selection. This study aimed…”
Get full text

Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? by Okuno, Masayuki, Newhook, Timothy E., Joechle, Katharina, Kawaguchi, Yoshikuni, De Bellis, Mario, Tzeng, Ching-Wei D., Chun, Yun S., Aloia, Thomas A., Shindoh, Junichi, Kaseb, Ahmed O., Vauthey, Jean-Nicolas

“…Hepatocellular carcinoma (HCC) de-differentiation is thought to correlate with size, therefore well-differentiated HCC ≥3 cm are considered rare and not fully…”
Get full text

Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes by Fang, Shenying, Wang, Yuling, Chun, Yun S., Liu, Huey, Ross, Merrick I., Gershenwald, Jeffrey E., Cormier, Janice N., Royal, Richard E., Lucci, Anthony, Schacherer, Christopher W., Reveille, John D., Chen, Wei, Sui, Dawen, Bassett, Roland L., Wang, Li-E, Wei, Qingyi, Amos, Christopher I., Lee, Jeffrey E.

“…Recent investigation has identified association of IL-12p40 blood levels with melanoma recurrence and patient survival. No studies have investigated…”
Get full text

Immune Checkpoint Inhibitor–Mediated Hepatobiliary Toxicity: What the Surgeon Should Know by Jain, Anish, Chun, Yun S

Get full text

Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study by Chun, Yun Shin, Huang, Min, Rink, Lori, Von Mehren, Margaret

“…The insulin-like growth factor (IGF) pathway is implicated in the pathogenesis of hepatocellular carcinoma (HCC) and may be important in nonalcoholic fatty…”
Get full text

Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations by Passot, Guillaume, MD, PhD, Chun, Yun S., MD, FACS, Kopetz, Scott E., MD, Overman, Michael J., MD, Conrad, Claudius, MD, PhD, Aloia, Thomas A., MD, FACS, Vauthey, Jean-Nicolas, MD, FACS

“…Abstract Background After resection of colorectal liver metastases (CLM), RAS mutations are associated with modest survival benefit and second-line…”
Get full text

Abstract 5568: Elevated interleukin-12 is a plasma marker of poor prognosis in stage III melanoma patients by Chun, Yun S, Wang, Yuling, Vo, Amy H, Liu, Huey, Wang, Daniel Y, Gershenwald, Jeffrey E, Cormier, Janice N, Ross, Merrick I, McClain, Dana M, Schacherer, Christopher W, Reveille, John D, Lee, Jeffrey E

“…Abstract Background: The heterodimeric cytokine interleukin-12 (IL-12) can both induce and suppress cellular immunity; the IL-12 p40 subunit is also a…”
Get full text

Immune regulation of IL-17 through NF-κB signaling pathway involved in the development of gastric cancer by LI Chun-bo, SU Yun, GONG Hong-xia, XUE Xuan, LI Ting-ting, NIU Shi-wei, NIE Peng

“…Objective To investigate the molecular mechanism of interleukin-17 in the development of gastric cancer through NF-κB signaling pathway. Methods Thirty…”
Get full text